STELLA EMERENINI: Open Payments
NPI 1073216685 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $215 |
| ABBVIE INC. | 8 | $196 |
| Janssen Pharmaceuticals, Inc | 2 | $148 |
| Axsome Therapeutics, Inc. | 3 | $139 |
| Alkermes, Inc. | 1 | $128 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: FANAPT, VRAYLAR, SPRAVATO, Auvelity, LYBALVI, ROTATEQ, COBENFY, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
